Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Berenberg lowers target price on Next Fifteen

(Sharecast News) - Analysts at Berenberg lowered their target price on advertising firm Next Fifteen from 790.0p to 660.0p on Tuesday, citing a "cautious outlook". Berenberg said Next Fifteen's FY25 results showed that group net revenue was down 1% year-on-year at £569.7m, while adjusted underlying earnings came to £107.5m, both of which were in line with consensus. Adjusted EPS was 69.3p, 3% below consensus.

The German bank also stated that Next Fifteen's balance sheet remained "robust", with net debt of £38.4m, and pointed out that the shares were trading on a FY26 price-to-earnings ratio of 5x.

In terms of the outlook, Next Fifteen's management noted that the group's current performance was broadly in line with internal expectations.

However, Berenberg adjusted its FY26 forecasts for Next Fifteen by reducing net revenue forecasts by 2%, adjusted underlying earnings by 6%, and adjusted EPS by 9%.

Reporting by Iain Gilbert at Sharescast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.